MANAGED ACCOUNT ADVISORS LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$20,000
-41.2%
4,079
-5.2%
0.00%
Q1 2015$34,000
-91.3%
4,305
-93.3%
0.00%
Q4 2014$391,000
+171.5%
64,527
+90.7%
0.00%
Q3 2014$144,000
-30.1%
33,829
+1.6%
0.00%
Q2 2014$206,000
-22.0%
33,302
-18.2%
0.00%
Q1 2014$264,000
+53.5%
40,725
+33.1%
0.00%
Q4 2013$172,000
-14.9%
30,587
-7.2%
0.00%
Q3 2013$202,000
-39.0%
32,968
-41.7%
0.00%
-100.0%
Q2 2013$331,00056,5080.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 3,000,000$5,160,0004.58%
Foresite Capital Management II, LLC 6,225,049$10,707,0003.59%
Scale Management, LLC 1,312,575$2,258,0003.46%
NEA Management Company, LLC 3,709,000$6,379,0000.41%
Cheyne Capital Management (UK) LLP 413,200$709,0000.38%
Rhenman & Partners Asset Management AB 1,189,000$2,045,0000.31%
SAMLYN CAPITAL, LLC 6,160,417$10,596,0000.22%
Rock Springs Capital Management LP 1,650,000$2,838,0000.22%
Palo Alto Investors LP 1,673,024$2,878,0000.16%
GLOBEFLEX CAPITAL L P 295,000$507,0000.14%
View complete list of OREXIGEN THERAPEUTICS INC shareholders